– Late-breaker poster highlights preclinical profile of ABI-6250, currently in Phase 1a with data anticipated in Q3 2025 – – Second poster describes in vitro studies of effects on viral infection ...
– ABI-5366 is currently being evaluated in ongoing Phase 1b clinical trial with interim proof-of-concept data expected in fall 2025 – SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- ...
Interim Data from the Phase 1b portion of the study in participants with recurrent genital herpes is expected in the first half of 2025. Part B of the study will evaluate weekly and monthly oral ...
TipRanks on MSN
Assembly Biosciences announces Phase 1b data for ABI-4334
Assembly Biosciences (ASMB) announced Phase 1b clinical data for its next-generation investigational capsid assembly modulator, CAM, ABI-4334 ...
CORAL GABLES, Fla.--(BUSINESS WIRE)--Assembly Software, creator of the cutting-edge case management software, Neos, is thrilled to announce the launch of a groundbreaking analytics product. Advanced ...
Mizuho analyst Salim Syed raised the firm’s price target on Assembly Biosciences (ASMB) to $40 from $29 and keeps an Outperform rating on the ...
Data Centers: Perhaps one of the biggest issues right now – at our dinner tables, in borough council meetings and across Pennsylvania. I’ve heard from a great number of area residents with varying ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback